Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer (Q37626056)
Jump to navigation
Jump to search
scientific article published on 14 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer |
scientific article published on 14 October 2013 |
Statements
1 reference
Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer (English)
1 reference
Norihiro Yamaguchi
1 reference
Antonio R Lucena-Araujo
1 reference
Sohei Nakayama
1 reference
Lorena L de Figueiredo-Pontes
1 reference
David A Gonzalez
1 reference
Hiroyuki Yasuda
1 reference
Susumu Kobayashi
1 reference
14 October 2013
1 reference
1 reference
37-43
1 reference
Identifiers
1 reference
1 reference
1 reference